Clinical trial Recruiting at 1 site Interventional Ages 1 Year and up

Radiation-free imaging to measure intestinal transit time in children

Official title: Contrast Enhanced Multispectral Optoacoustic Tomography and MRI for Non-invasive Assessment of Intestinal Transit Time in Children With Chronic Bowel Emptying Disorders

Run by Friedrich-Alexander-Universität Erlangen-Nürnberg · NCT06911749 · Data updated 2026-11-12

This project will try a radiation-free imaging method (MSOT) with an oral dye plus MRI to measure how quickly stool moves through the intestines in children and teenagers with chronic bowel emptying disorders.

More Chronic Constipation trials

Quick facts

Study typeInterventional
Ages1 Year and up
SexAll
Enrollment20 (estimated)
SponsorFriedrich-Alexander-Universität Erlangen-Nürnberg
Academic / other
Drugs / interventionsradiation
Locations1 site (Erlangen, Bavaria)
StatusRecruiting
StartedApril 15, 2025
Main results expectedJanuary 1, 2026
Study endsJune 1, 2026
Registry record updatedSeptember 3, 2025
Trial IDNCT06911749 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents up to 17 years with suspected or confirmed chronic bowel emptying disorders whose guardians can provide written consent and who can attend the University Hospital Erlangen are the intended participants.

Probably not a fit

Patients with known hypersensitivity to ICG or iodine, significant subcutaneous fat thickness over the scan area (>3 cm), tattoos at the examination site, thyroid dysfunction, infants under 1 year, or those unable to travel to Erlangen are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This monocentric project at University Hospital Erlangen uses Multispectral Optoacoustic Tomography (MSOT) together with orally administered Indocyanine Green (ICG) to track gastrointestinal transit time in pediatric patients. A contrast-free MRI technique will also be used to visualize peristalsis of intestinal segments without radiation. The protocol aims to standardize how images and clinical data are collected after ICG administration and to compare MSOT findings with MRI and clinical presentation. The approach targets children and adolescents up to 17 years old with suspected or confirmed chronic defecation disorders of various causes.

Why it matters

Potential benefit: If successful, this could offer a non-invasive, radiation-free way to measure intestinal transit and help guide treatment choices for children with chronic constipation and related disorders.

How similar studies have gone: Using MSOT with oral ICG for gastrointestinal transit in children is experimental with limited prior clinical data, while contrast-free MRI for intestinal motility has been used in research settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patient Group

* Written informed consent from the participant (starting at age 6).
* Written informed consent from the legal guardian(s).
* Suspected or confirmed diagnosis of chronic defecation disorder.
* Age ≤ 18 years.
* Willingness and ability to participate, with sufficient German language skills to understand the informed consent document.

Control Group

* Written informed consent from the participant.
* Age \> 18 years.
* BMI \< 25 or medical suitability for MSOT examination as assessed by a physician.
* Willingness and ability to participate, with sufficient German language skills to understand the informed consent document.

Exclusion Criteria:

* Age \< 1 year.
* Pregnancy or breastfeeding.
* Tattoos in the examination area.
* Subcutaneous fat tissue thickness \> 3 cm.
* Known hypersensitivity to ICG, sodium iodide, or iodine.
* Thyroid dysfunction, including hyperthyroidism or focal/diffuse thyroid autonomy.
* Recent thyroid function testing with radioactive iodine treatment (within two weeks before or after the study).
* Impaired renal function.
* Use of specific medications, including:

  * Beta-blockers,
  * Anticonvulsants,
  * Cyclopropane,
  * Bisulfite compounds,
  * Haloperidol,
  * Heroin,
  * Meperidine,
  * Metamizole,
  * Methadone,
  * Morphine,
  * Nitrofurantoin,
  * Opium alkaloids,
  * Phenobarbital,
  * Phenylbutazone,
  * Probenecid,
  * Rifamycin,
  * Any injection containing sodium bisulfite.
* General contraindications for MRI, such as electrical implants (e.g., pacemakers, perfusion pumps).
* Severe claustrophobia preventing MRI examination.

Where it's running

  • University Hospital Erlangen, Pediatric Surgery
    Erlangen, Bavaria, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.